Furthermore, the IL-3-dependent effects appeared to be mediated by monocytes and macrophages, further emphasizing the complex interactions between tumor, bone, and immune cells over the evolution of MM bone disease (119). This evidence concerns the gene IL3 and Miyoshi myopathy.